title: Decline in ischaemic heart disease in Iceland and change in risk factor levels.
abstract: OBJECTIVE
  To monitor trends in mortality and morbidity due to ischaemic heart disease and compare these with observed levels of risk factors from population surveys.
  
  
  METHODS
  Analysis of trends in death rates from ischaemic heart disease in Iceland compared with expected rates computed from population surveys. Risk factor levels together with beta factors obtained from Cox's regression analysis were used to compute expected death rates. Trends in morbidity due to acute myocardial infarction were assessed and secular trends in dietary consumption compared with trends in cholesterol concentrations.
  
  
  METHODS
  Reykjavik, Iceland (total population 250,000; over half the population live in Reykjavik).
  
  
  METHODS
  12,814 randomly selected residents in the Reykjavik area aged 45-64 (6623 men, 6191 women; 72% and 80% of those invited).
  
  
  METHODS
  Age adjusted rates of myocardial infarction and deaths from ischaemic heart disease. Expected risk from risk factor levels (smoking, total serum cholesterol concentration, systolic blood pressure) at each unique survey visit.
  
  
  RESULTS
  Mortality from ischaemic heart disease has decreased by 17-18% since 1970. During 1981-6 the myocardial infarction attack rate in men under 75 decreased by 23%. A decrease occurred in the level of all three major risk factors after 1968. The fall in the serum cholesterol concentration coincided with a reduction in consumption of dairy fat and margarine. The calculated reduction in risk for the age group 45-64 was about 35%, which was closely similar to the observed decrease in mortality due to ischaemic heart disease in that age group.
  
  
  CONCLUSIONS
  The reduction in mortality from ischaemic heart disease was substantially due to a decreased incidence of myocardial infarction and could be attributed largely to the reduction in risk factors.
authors.affiliation: Icelandic Heart Association, Reykjavik.
authors.forename: N
authors.initials: N
authors.lastname: Sigfusson
authors.forename: H
authors.initials: H
authors.lastname: Sigvaldason
authors.forename: L
authors.initials: L
authors.lastname: Steingrimsdottir
authors.forename: I I
authors.initials: II
authors.lastname: Gudmundsdottir
authors.forename: I
authors.initials: I
authors.lastname: Stefansdottir
authors.forename: T
authors.initials: T
authors.lastname: Thorsteinsson
authors.forename: G
authors.initials: G
authors.lastname: Sigurdsson
mesh_terms: D001794:Blood Pressure / Q000502:physiology*; D002784:Cholesterol / Q000097:blood*; D003327:Coronary Disease / Q000453:epidemiology / Q000209:etiology / Q000401:mortality*; D004032:Diet / Q000639:trends; D004041:Dietary Fats / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007055:Iceland / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000453:epidemiology; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects*
chemical_list: D004041:Dietary Fats; D002784:Cholesterol